This publication is a systematic review and meta-analysis that examines the effects of Detached Mindfulness (DM) as a stand-alone intervention for obsessive–compulsive disorder and panic disorder, based on clinical or non-clinical samples aged 17 or older. The analysis included 256 participants, though the setting and comparator were not reported. The scope focuses on symptom reductions as the primary outcome and depressive symptoms as a secondary outcome, with follow-up noted to lack long-term data.
The key findings from the meta-analysis indicate large symptom reductions for primary outcomes, with a pooled Hedges’ g of –1.80 (95% CI [–2.84, –0.76]). For depressive symptoms, reductions were also observed, with a pooled Hedges’ g of –1.15 (95% CI [–2.23, –0.08]). The authors describe this as converging, but still limited, evidence, without overstating causality due to the observational nature of the included studies. Safety data, including adverse events and tolerability, were not reported.
Limitations acknowledged by the authors include a small number of studies, methodological shortcomings, and a lack of long-term follow-up. The practice relevance is framed cautiously, with implications for future component analyses of metacognitive therapy and the development of brief, transdiagnostic metacognitive interventions. Given the evidence base limitations, clinicians should interpret these findings as preliminary and consider them in the context of broader treatment options.
View Original Abstract ↓
BackgroundDetached Mindfulness (DM) is a central, transdiagnostic technique within Metacognitive Therapy (MCT). It involves increasing meta-awareness of intrusions while decentring from and disengaging with them, and is used to reduce the Cognitive Attentional Syndrome and dysfunctional metacognitive beliefs—key components of the metacognitive model of psychological disorders. Although DM is typically delivered within a full MCT protocol, recent research has begun to evaluate DM as a stand-alone intervention. The current study aimed to systematically review and meta-analyse its effects.MethodsStudies were included in the systematic review if they examined DM delivered as a stand-alone intervention in clinical or non-clinical samples. Searches were carried out in PubMed, Scopus, Web of Science, and Google Scholar in May 2025. Methodological quality and risk of bias were assessed using an adapted quality appraisal checklist. Random-effects meta-analyses were conducted for clinical trials, and narrative synthesis for experimental studies.ResultsFourteen studies met inclusion criteria, representing twelve independent samples exposed to DM (N = 256; all aged ≥17). Three samples evaluated DM as a stand-alone treatment in clinical trials (two in obsessive–compulsive disorder and one in panic disorder). Of the remaining nine samples, seven (one clinical, six non-clinical) examined the effects of DM on experimentally induced psychological symptoms, and two (non-clinical) on pre-existing symptoms. Across the three clinical trials, DM was associated with large symptom reductions (pooled Hedges’ g for primary outcomes = −1.80, 95% CI [−2.84, −0.76]; pooled g for depressive symptoms measured as a secondary outcome = −1.15, 95% CI [−2.23, −0.08]. Of the remaining nine samples, eight reported beneficial effects of DM on at least one outcome, with significant effects typically in the medium-to-large range.ConclusionsThese findings provide converging, but still limited, evidence that DM as a stand-alone intervention is associated with improvements in psychological symptoms and related processes. The results have implications for future component analyses of MCT and for the development of brief, transdiagnostic metacognitive interventions. However, there are significant limitations to the current research base including the small number of studies, methodological shortcomings, and lack of long-term follow-up; these are discussed as well as suggestions for future studies.